|
 |
 |

NEWS
INDEX
Archives
2005
October
Study: 'Run-down' feeling
with illness may last longer as people age
Molly McElroy,
News Bureau
217-333-5802; mmcelroy@uiuc.edu
10/11/05
 |
Click
photo to enlarge |
| Photo
by Kwame Ross |
| Rodney
W. Johnson, a professor of integrative immunology
and behavior in the department of animal sciences,
says aging may intensify and prolong feeling run down
when common infections like the flu occur. |
|
|
CHAMPAIGN, Ill.
— Aging may intensify and prolong feeling run down when common
infections like the flu occur, according to researchers at the University
of Illinois at Urbana-Champaign.
A new study, done with mice and published in the Federation of the American
Societies of Experimental Biology Journal, suggests that miscommunication
between the immune system and brain may be to blame for extended sickness
symptoms and other cognitive disorders in elderly people and animals
with an infection.
“In the course of our other studies on inflammation and aging,
we repeatedly saw that old animals suffered an exaggerated inflammatory
response in the brain compared to younger adults when their peripheral
immune system was experimentally activated,” said Rodney W. Johnson,
a professor of integrative immunology and behavior in the department
of animal sciences. “Knowing
the role of brain inflammation in behavioral deficits and neurodegenerative
diseases, we felt this could be important, especially because immunity
is often suppressed in the elderly, making them more susceptible to
infections.”
Johnson and his colleagues compared behavior in young adult and aged
mice that were made temporarily ill by exposure to lipopolysaccharide
(LPS), a molecule present on E. coli and other gram-negative bacteria
that strongly activates the immune system.
“When a person or pet develops an infection, their behavior changes:
They stop eating; they become lethargic; they have reduced cognitive
abilities,” Johnson said.
How do you know a mouse feels sick? Like unhealthy humans, mice show
decreased appetite, weight loss and less social interaction, said Johnson,
who likened his own lack of interest in getting up off the couch to
greet visitors when he is sick to a mouse’s lack of curiosity
about new cage mates when it is sick.
LPS injections caused older mice to stop eating for a longer amount
of time, lose more weight and show less social behavior than younger
mice.
“As expected, young adults showed signs of improvement eight hours
after LPS treatment and fully recovered by the next day, but the aged
animals still were 50 to 60 percent depressed,” Johnson said.
“We’ve completed follow-up studies that show aged animals
are still depressed three to four days later.”
Johnson and colleagues also studied how aging affects the response of
microglial cells – key immune cells in the brain – during
a peripheral infection.
It is important that the peripheral immune system inform the brain of
an infection, Johnson said. “The peripheral immune system signals
microglia to secrete inflammatory cytokines that cause behavioral changes.”
In many ways microglia act as the Red Cross, he added. They can converge
upon sites of injury in the brain to scour away neuronal debris and
begin repairs, and during a peripheral infection the cytokines they
produce cause behavioral changes that support convalescence and healing.
However, if microglia overreact, the result can be pathological.
Johnson’s study, which was published in August, revealed that
older animals had an exaggerated inflammatory cytokine response in the
brain compared with young animals when the peripheral immune system
was stimulated with LPS.
“In the old animals, the message of a peripheral infection is
conveyed to the brain, but the cells in the brain have an exaggerated
response and produce more inflammatory cytokines than what is typical,”
Johnson said. “The exaggerated response can lead to a more intense
and longer-lasting sickness behavior syndrome.”
To study the phenomenon further, Johnson and colleagues examined the
expression of more than 39,000 genes in the brain using microarray technology.
The approach was helpful, because the gene expression pattern indicated
brain inflammation emerged during aging. The emergence of a mild but
chronic neuroinflammatory state appears to have a priming effect on
microglial cells, Johnson said.
“Chronic neurodegenerative diseases prime microglia so that when
an individual develops a peripheral infection, these cells overreact
and exacerbate neurodegenerative disease,” he said. “Peripheral
infection is now recognized as a significant risk factor for relapse
for multiple sclerosis, for example, and peripheral infection is a risk
factor for delirium in Alzheimer’s patients.”
The research suggests that normal aging also may prime microglia, Johnson
said.
The six co-authors with Johnson on the study were postdoctoral researcher
Jonathan P. Godbout; research associate Jing Chen; graduate students
Jayne Abraham, Amy F. Richwine and Brian M. Berg; and Keith W. Kelley,
a professor of integrative immunology and behavior in the department
of animal sciences.
Funding was provided by the National Institutes of Health. Godbout,
now a professor at Ohio State University, was supported by a National
Research Service Award from the National Institutes of Health to the
U. of I.’s Division of Nutritional Sciences.
|
 |
 |
|